4//SEC Filing
Bagarazzi Mark 4
Accession 0001055726-18-000005
CIK 0001055726other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 7:44 PM ET
Size
13.6 KB
Accession
0001055726-18-000005
Insider Transaction Report
Form 4
Bagarazzi Mark
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2018-03-05+8,333→ 51,443 total - Tax Payment
Common Stock
2018-03-05$4.29/sh−2,815$12,076→ 48,628 total - Exercise/Conversion
Restricted Stock Unit
2018-03-05−8,333→ 0 total→ Common Stock (8,333 underlying) - Award
Common Stock Option
2018-03-05+126,500→ 126,500 totalExercise: $4.29From: 2018-03-05Exp: 2028-03-05→ Common Stock (126,500 underlying) - Award
Restricted Stock Unit
2018-03-05+82,700→ 82,700 total→ Common Stock (82,700 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 25,000 restricted stock units was as follows: 8,334 shares vested on March 5, 2016; 8,333 shares vested on March 5, 2017; 8,333 shares vested on March 5, 2018. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.
- [F2]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.
- [F3]The vesting schedule for the 126,500 options is as follows: 31,625 shares vested on March 5, 2018; 31,625 shares will vest on March 5, 2019; 31,625 shares will vest on March 5, 2020; 31,625 shares will vest on March 5, 2021.
- [F4]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 82,700 restricted stock units is as follows: 27,567 shares will vest on March 5, 2019; 27,567 shares will vest on March 5, 2020; 27,566 shares will vest on March 5, 2021. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.
Documents
Issuer
INOVIO PHARMACEUTICALS, INC.
CIK 0001055726
Entity typeother
Related Parties
1- filerCIK 0001539067
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 7:44 PM ET
- Size
- 13.6 KB